Ledger.Open graph →
SEC Form D · filed April 30, 2015

MyoKardia Inc

Offering
$46.0M
Sold
$46.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Kevin Starr · South San Francisco, CADirectorCharles Homcy · South San Francisco, CADirectorMark Perry · South San Francisco, CADirectorKatherine Bowdish · South San Francisco, CADirectorTassos A. Gianakakos · South San Francisco, CAExec · DirectorKevin Starr · Boston, MADirectorKevin Starr · Boston, MADirectorCharles Homcy · South San Francisco, CADirectorMark Perry · Berkeley, CADirectorKatherine Bowdish · South San Francisco, CADirectorTassos A. Gianakakos · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗